|
Baseline characteristics of 17 pts with HCM |
|
| Clinical parameters |
|
| Patients, n |
17 |
| Males/Females, n (%) |
9 (53%)/8(47%) |
| Age (years-mean ± SD) |
53 ± 16 |
| NYHA II, n (%) |
14 (82%) |
| NYHA III, n (%) |
3 (18%) |
| Therapy, n (%) |
|
| Beta-blocker |
11 (65%) |
| Calcium antagonist |
4 (23%) |
| Beta-blocker and calcium antagonist |
2 (12%) |
| Echocardiographic parameters (LLD) |
|
| LVOT gradient > 30 mmHg at rest, n (%) |
11 (65%) |
| Mitral regurgitation at rest, n (%) |
9 (53%) |
| Left ventricular end diastolic diameter (mm) |
47 ± 4 |
| Left ventricular end systolic diameter (mm) |
29 ± 4 |
| Interventricular septum thickness (mm) |
17 ± 4,1 |
| Posterior wall thickness (mm) |
9 ± 2,4 |
| Fractional shortening (%) |
37 ± 5 |
|
NYHA = New York Heart Association LVOT = left ventricular outflow tract | |
Miranda et al. Cardiovascular Ultrasound 2008 6:19 doi:10.1186/1476-7120-6-19 |
|